Skip to main content
Clinical Trials/NL-OMON48192
NL-OMON48192
Withdrawn
Not Applicable

*Evaluating the effect of qualitative feedback on asthma control in adults with difficult to treat asthma by improving therapy adherence and inhalation technique* - IMAGINE II

Medisch Spectrum Twente0 sites68 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Spectrum Twente
Enrollment
68
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients from 18 years or older.
  • \- Patients who suffer from difficult to treat asthma.
  • \- Patients are under treatment in MST

Exclusion Criteria

  • \- Patients who are unable to speak or understand the Dutch language.
  • \- Current smokers
  • \- Patients who are not compatible with the medication delivered through the
  • Nexthaler, Ellipta or Spiromax. Switch between dosis aerosol and dry powder
  • inhaler device is allowed if the medication remains the same. Patients should
  • use this device at least a month before entering the study.
  • \- Patients with a chronic disease other than asthma that can influence the lung
  • \- Patients who use a biological drug for their asthma

Outcomes

Primary Outcomes

Not specified

Similar Trials